SORIATANE (Stiefel Laboratories Inc)
Welcome to the PulseAid listing for the SORIATANE drug offered from Stiefel Laboratories Inc. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Stiefel Laboratories Inc |
| NON-PROPRIETARY NAME: | acitretin |
| SUBSTANCE NAME: | ACITRETIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1996-11-01 |
| END MARKETING DATE: | 0000-00-00 |
SORIATANE HUMAN PRESCRIPTION DRUG Details:
| Item Description | SORIATANE from Stiefel Laboratories Inc |
| LABELER NAME: | Stiefel Laboratories Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 1996-11-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0145-0090_630f02b6-2d64-4d78-987a-2c546ad5efeb |
| PRODUCT NDC: | 0145-0090 |
| APPLICATION NUMBER: | NDA019821 |
Other ACITRETIN Pharmaceutical Manufacturers / Labelers:
